News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,608 Results
Type
Article (40997)
Company Profile (300)
Press Release (673310)
Multimedia
Podcasts (88)
Webinars (14)
Section
Business (207213)
Career Advice (2077)
Deals (35913)
Drug Delivery (100)
Drug Development (82491)
Employer Resources (176)
FDA (16327)
Job Trends (15202)
News (350454)
Policy (32941)
Tag
Academia (2576)
Accelerated approval (10)
Adcomms (22)
Allergies (96)
Alliances (50372)
ALS (110)
Alzheimer's disease (1470)
Antibody-drug conjugate (ADC) (160)
Approvals (16322)
Artificial intelligence (319)
Autoimmune disease (29)
Automation (19)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (125)
Biotechnology (212)
Bladder cancer (94)
Brain cancer (37)
Breast cancer (369)
Cancer (2896)
Cardiovascular disease (219)
Career advice (1735)
Career pathing (33)
CAR-T (186)
CDC (33)
Cell therapy (507)
Cervical cancer (22)
Clinical research (67922)
Collaboration (1034)
Company closure (3)
Compensation (694)
Complete response letters (25)
COVID-19 (2649)
CRISPR (56)
C-suite (337)
Cystic fibrosis (113)
Data (3026)
Decentralized trials (2)
Denatured (28)
Depression (66)
Diabetes (347)
Diagnostics (6445)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (139)
Drug pricing (127)
Drug shortages (28)
Duchenne muscular dystrophy (128)
Earnings (88505)
Editorial (46)
Employer branding (23)
Employer resources (152)
Events (116217)
Executive appointments (864)
FDA (17997)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (938)
Gene editing (131)
Generative AI (23)
Gene therapy (382)
GLP-1 (815)
Government (4552)
Grass and pollen (5)
Guidances (181)
Healthcare (18925)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (148)
Immuno-oncology (10)
Indications (40)
Infectious disease (2821)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (62)
Intellectual property (121)
Interviews (329)
IPO (16829)
IRA (45)
Job creations (3844)
Job search strategy (1471)
Kidney cancer (13)
Labor market (52)
Layoffs (510)
Leadership (24)
Legal (7979)
Liver cancer (79)
Longevity (12)
Lung cancer (402)
Lymphoma (210)
Machine learning (11)
Management (58)
Manufacturing (394)
MASH (95)
Medical device (13482)
Medtech (13487)
Mergers & acquisitions (19812)
Metabolic disorders (868)
Multiple sclerosis (99)
NASH (16)
Neurodegenerative disease (116)
Neuropsychiatric disorders (35)
Neuroscience (2161)
NextGen: Class of 2025 (6578)
Non-profit (4507)
Now hiring (48)
Obesity (439)
Opinion (237)
Ovarian cancer (102)
Pain (108)
Pancreatic cancer (120)
Parkinson's disease (188)
Partnered (22)
Patents (301)
Patient recruitment (168)
Peanut (50)
People (58567)
Pharmaceutical (76)
Pharmacy benefit managers (22)
Phase I (21199)
Phase II (29976)
Phase III (22194)
Pipeline (1649)
Policy (213)
Postmarket research (2573)
Preclinical (9023)
Press Release (64)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (463)
Real estate (6041)
Recruiting (68)
Regulatory (22906)
Reports (50)
Research institute (2349)
Resumes & cover letters (355)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (88)
Series A (158)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (20)
Spinal muscular atrophy (148)
Sponsored (34)
Startups (3671)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (61)
The Weekly (58)
Vaccines (797)
Venture capital (56)
Weight loss (266)
Women's health (50)
Worklife (20)
Date
Today (96)
Last 7 days (371)
Last 30 days (1853)
Last 365 days (31540)
2025 (17039)
2024 (35731)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54536)
2019 (46982)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (743)
Alabama (66)
Alaska (7)
Arizona (246)
Arkansas (14)
Asia (39530)
Australia (6372)
California (7492)
Canada (2371)
China (698)
Colorado (324)
Connecticut (322)
Delaware (194)
Europe (85398)
Florida (1133)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (642)
India (27)
Indiana (364)
Iowa (16)
Japan (230)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1039)
Massachusetts (5607)
Michigan (246)
Minnesota (455)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2101)
New Mexico (29)
New York (2103)
North Carolina (1137)
North Dakota (8)
Northern California (3293)
Ohio (237)
Oklahoma (16)
Oregon (35)
Pennsylvania (1617)
Puerto Rico (18)
Rhode Island (36)
South America (1123)
South Carolina (34)
South Dakota (1)
Southern California (2803)
Tennessee (126)
Texas (1139)
United States (27895)
Utah (221)
Virginia (190)
Washington D.C. (73)
Washington State (645)
West Virginia (4)
Wisconsin (66)
714,608 Results for "xeris biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
May 9, 2025
·
13 min read
Press Releases
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
May 1, 2025
·
1 min read
Press Releases
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
February 27, 2025
·
2 min read
Press Releases
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
March 6, 2025
·
15 min read
Business
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
Xeris Biopharma Holdings, Inc. announced financial results for the first quarter ended March 31, 2024 and recent events.
May 9, 2024
·
10 min read
Press Releases
Xeris Announces Details for Analyst & Investor Day
May 20, 2025
·
8 min read
BioMidwest
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Xeris Biopharma Holdings, Inc. announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 at 11:00 am Eastern Time.
April 2, 2024
·
1 min read
Drug Development
5 Second-Half Biopharma Milestones To Watch
After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in 2025, according to Jefferies.
July 7, 2025
·
8 min read
·
Tristan Manalac
Business
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
Xeris Biopharma Holdings, Inc. announced that the Company will release its first quarter 2024 financial results before the open of the U.S. financial markets on Thursday, May 9, 2024.
May 2, 2024
·
2 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
July 3, 2025
·
1 min read
·
Angela Gabriel
1 of 71,461
Next
